Jushi Beats All Expectations: Cannabis Company Surpasses Analysts’ 4Q23 Sales And Profit Forecasts
The multi-state cannabis company Jushi Holdings (OTC: JUSHF), reported a significant increase in unique patient visits in Virginia, indicating robust growth in the fourth quarter of 2023.
Sales reached $67.8 million, exceeding the FactSet consensus of $65.3 million, while adjusted EBITDA stood at $11.3 million surpassing the expected $10.5 million.
Jushi outperformed financial experts’ expectations in both sales and profits, noted analyst Pablo Zuanic from Zuanic & Associates in a recent equity research report.
Want to talk more about companies like this and what to expect from their valuations, earnings, and of course, investment opportunities? Join us at the upcoming Benzinga Cannabis Capital Conference in Florida at the new Hollywood venue on April 16 and 17, 2024.
Financial Health And Market Position
Despite challenges, Jushi’s balance sheet remains manageable, with a notable improvement in free cash flow trends achieving break-even levels in 3Q23 and 4Q23.
The company aims to handle its $55 million debt due by December 2024 through non-dilutive strategies, ensuring that …
Full story available on Benzinga.com